Cargando…

Phenotyping pulmonary hypertension in systemic sclerosis: a moving target

Detalles Bibliográficos
Autores principales:	Mercurio, Valentina, Hassoun, Paul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055257/ https://www.ncbi.nlm.nih.gov/pubmed/29938583 http://dx.doi.org/10.1177/2045894018785247

Ejemplares similares

Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact
por: Naranjo, Mario, et al.
Publicado: (2021)

Clinical features of pulmonary arterial hypertension associated with systemic sclerosis
por: Tuhy, Tijana, et al.
Publicado: (2023)

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
por: Attanasio, Umberto, et al.
Publicado: (2020)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2022)

Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
por: Hassoun, Paul M., et al.
Publicado: (2021)

When more is more: the role of additional upfront therapy in pulmonary arterial hypertension
por: Niedermeyer, Shannon, et al.
Publicado: (2023)

Myocardial Fibrosis as a Potential Maladaptive Feature of Right Ventricle Remodeling in Pulmonary Hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Pulmonary hypertension in systemic sclerosis: different phenotypes
por: Launay, David, et al.
Publicado: (2017)

Pulmonary hypertension phenotypes in patients with systemic sclerosis
por: Haque, Ashraful, et al.
Publicado: (2021)

Improved Survival for Patients with Systemic Sclerosis–associated Pulmonary Arterial Hypertension: For Real?
por: Xanthouli, Panagiota
Publicado: (2022)

Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans
por: Blanco, Isabel, et al.
Publicado: (2014)

Unique Predictors of Mortality in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis in the REVEAL Registry
por: Chung, Lorinda, et al.
Publicado: (2014)

Early Detection of Pulmonary Vascular Dysfunction in Neonatal Bronchopulmonary Dysplasia
por: Hassoun, Paul M.
Publicado: (2020)

The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis
por: Lee, Michael H, et al.
Publicado: (2019)

The Importance of Echocardiographic Screening for Pulmonary Arterial Hypertension in Korean Patients with Systemic Sclerosis
por: Kim, Hack-Lyoung
Publicado: (2016)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases
por: Boueiz, Adel, et al.
Publicado: (2014)

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension
por: Simpson, Catherine E., et al.
Publicado: (2019)

Beta-blockers and the treatment of hypertension: it is time to move on
por: Wiysonge, Charles Shey, et al.
Publicado: (2007)

Cardiac sympathetic dysfunction in pulmonary arterial hypertension: lesson from left-sided heart failure
por: Mercurio, Valentina, et al.
Publicado: (2019)

Idiopathic pulmonary fibrosis: moving forward
por: Richeldi, Luca
Publicado: (2015)

Optimal Systemic Treatment of Advanced Bladder Cancer—A Moving Target
por: Pappot, Helle, et al.
Publicado: (2020)

The moving target of psychiatric diagnosis
por: Alda, Martin
Publicado: (2021)

Multifactorial Pulmonary Hypertension in Systemic Sclerosis
por: Hussain, Habiba, et al.
Publicado: (2020)

Moving Beyond the Endothelium is Still Challenging-Complex Interplay between Endothelin and Reactive Oxygen Species in Pulmonary Arterial Hypertension
por: Chung, Hyemoon, et al.
Publicado: (2019)

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction
por: Bourji, Khalil I., et al.
Publicado: (2017)

Safety in healthcare is a moving target
por: Vincent, Charles, et al.
Publicado: (2015)

New Therapeutic Target for Pulmonary Arterial Hypertension
por: Yoon, Kyung Lim
Publicado: (2018)

Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick
por: Klompas, Michael, et al.
Publicado: (2016)

Biomarkers for Pulmonary Vascular Remodeling in Systemic Sclerosis: A Pathophysiological Approach
por: Odler, Balazs, et al.
Publicado: (2018)

Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography
por: Mercurio, Valentina, et al.
Publicado: (2022)

Metastatic cells: moving onco-targets
por: Patsialou, Antonia, et al.
Publicado: (2014)

Defining minimal detectable difference in echocardiographic measures of right ventricular function in systemic sclerosis
por: Mukherjee, Monica, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

HYPERTENSION TARGETS - MOVING THE GOALPOSTS AGAIN!
por: Sharkey, N, et al.
Publicado: (2019)

Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension
por: Naranjo, Mario, et al.
Publicado: (2022)

Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact
por: Mercurio, Valentina, et al.
Publicado: (2018)

Prognosis for Mechanically Ventilated Patients: A Moving Target
por: Zaeh, Sandra E., et al.
Publicado: (2020)

Targeting ATP-Sensitive K(+) Channels to Treat Pulmonary Hypertension
por: Breen, Ellen, et al.
Publicado: (2022)

Pulmonary Hypertension: Unveiling Molecular Mechanisms, Diagnosis, and Therapeutic Targets
por: Gredic, Marija, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l5hec3nbh43eprls6hpul5uauj